Mechanical Ventilators Market size exceeded USD 9.6 billion in 2020 and is estimated to witness -8% CAGR between 2021 and 2027. The surging elderly population along with the growing incidence of chronic respiratory disorders is anticipated to boost the demand for mechanical ventilators. Significant rising awareness of lung cancer symptoms and an increase in hospital admissions will fortify the demand for excellent treatment choices offering enormous growth opportunities.
However, risks associated with the use of mechanical ventilators may have a negative impact on the industry growth. The risk of infection owing to the entry of germs through artificial airway requires longer mechanical ventilation. Further, lung damage may occur due to inflation or repetitive opening & collapsing of the small air sacs of the lungs. Thus, risks associated with the use of devices may hamper the demand.
The COVID-19 pandemic has proven to be beneficial for mechanical ventilators market and rendered a positive impact on the market statistics. The requirement for ventilation facilities by the coronavirus outbreak rapidly augmented several day-to-day operational capabilities. The American Association for Respiratory Care (AARC) collaborated with the different organizations to train respiratory therapists on operating ventilators during COVID-19. This has further encouraged the industry players to upsurge their production capacities to meet the increased demand.
The U.S. FDA had undertaken several initiatives during the COVID-19 public health emergency to ensure both patients and health care providers have continuous and timely availability of high-quality mechanical ventilators to respond effectively. The WHO is also operated in collaboration with industry players, government organizations, and Pandemic Supply Chain Network among others to drive the production of mechanical ventilators to meet rising global demand for critically affected and at-risk countries.
|Market Size in 2020:||9,646.4 Million (USD)|
|Forecast Period:||2021 to 2027|
|Forecast Period 2021 to 2027 CAGR:||-8.0%|
|2027 Value Projection:||2,457.5 Million (USD)|
|Historical Data for:||2016 to 2020|
|No. of Pages:||450|
|Tables, Charts & Figures:||920|
|Segments covered:||Product, Interface, Ventilator Type, Application, Mode, End-use, and Region|
|Pitfalls & Challenges:|
Growing prevalence of chronic respiratory diseases
Significant increase in the number of patients with chronic respiratory diseases will primarily fuel the mechanical ventilators market demand. Tuberculosis (TB) is one of the top 10 causes of death and the leading cause from a single infectious agent. Post-TB effects include chronic obstructive pulmonary disease, bronchiectasis, and pneumonia among others. Lung cancer (LC) is one of the most common cancers and the major cause of cancer mortality in the world. For instance, according to the World Health Organization (WHO) in 2020, above 2.2 million lung cancer cases were diagnosed with 1.8 million deaths worldwide.
Clinical advantages offered by intensive care ventilators
The intensive care ventilators segment valued at around USD 8.1 billion in 2020 on account of the several clinical benefits for a patient that has complications in breathing, acute respiratory failure, or compromised lung function. These mechanical ventilators are widely used in healthcare facilities in order to offer ventilatory support and maintain suitable ventilation. These ventilator manufacturers are focusing on the significance of monitoring lung mechanics to detect the different phenotypes of COVID-19 and personalize the treatment accordingly. Featuring invasive & non-invasive ventilation mode, advanced monitoring, visual decision support, the intensive care mechanical ventilators are expected to positively influence the mechanical ventilators market share.
Factors including cost-effective performance and minimal maintenance
The non-invasive ventilation segment accounted for more than 21% of the market share in 2020 and is projected to observe substantial growth through 2027. The use of non-invasive mechanical ventilation in a broad range of applications and the ability to provide precise & higher concentrations of oxygen is likely to propel the segment growth. The non-invasive ventilation can be delivered using advanced intensive care ventilators that can provide a range of respiratory support modes. This type of ventilation efficiently upsurges tidal volume, unloads the respiratory muscles, and decreases the diaphragmatic work of breathing those results in an enhancement in oxygenation, improvement in dyspnea, etc.
Surging demand for novel mechanical ventilators among adult COPD & asthma patients
The adult ventilators segment of mechanical ventilators market is poised to reach about USD 2,237 million by 2027 impelled by the significant adult population suffering from diseases such as COPD, asthma, etc. An increasing number of adult populations suffering from the chronic obstructive pulmonary disease (COPD) across the globe is one of the prime factors augmenting the market revenue.
Increasing adoption of mechanical ventilators in anaesthesiology
The mechanical ventilators market from anaesthesiology segment is slated to surpass nearly USD 248 million by 2027 fuelled by several factors comprising the increasing use of ventilators during general anesthesia. In the U.S., general anaesthetics are administered to around 50 million patients every year. As the world population is increasing rapidly and advanced anesthesia becomes available to more regions of the world, the global use of mechanical ventilators will grow significantly. Moreover, the advent of novel mechanical ventilators delivers data that may assist clinicians to maintain their desired inspired oxygen concentration during low & minimum flow anaesthesia.
Innovations and the advent of novel technologies in mechanical ventilators
The control mode ventilators are forecast to cross USD 839 million revenue by 2027. The control mode ventilator offers several benefits including delivers the preset volume or pressure regardless of the patient’s own inspiratory efforts. The facility to have direct control of airway pressure help in the prevention of lung injury. The volume control ventilation allows the patient to breathe spontaneously between the mandatory mechanical breaths, thereby surge the minute volume. Similarly, pressure control mode assists in adjusting the flowrate to keep the airway pressure at the set level.
Several advantages delivered by hospitals in ventilatory support
The hospitals end use dominated with over 59% of the mechanical ventilators market share in 2020 led by the increasing hospitals expenditure that enables the adoption of technologically advanced ventilators. However, the availability of trained health care providers to operate these ventilators, emphasis on providing quality care, and enhanced productivity of hospitals is stimulating the business revenue. The expansion of the hospital chain with developing infrastructure offering better diagnosis & treatment services for a wide range of respiratory diseases is set to proliferate the market growth.
Easy accessibility to novel technologies surges the preference for chronic respiratory diseases treatment in hospitals. Additionally, continuous monitoring delivered in hospitals is expected to upsurge the patient preference for these healthcare facilities.
Easy accessibility to technologically advanced products in the North America
U.S. dominated the North American market in 2020 and is predicted to exceed USD 413 million by 2027. Growing prevalence of chronic respiratory diseases, the presence of major players in the country, and easy accessibility to technologically advanced ventilators among others is boosting the regional industry growth. With the rising disease burden, the number of treatment procedures is also increasing that will drive the product demand.
Strategies implemented by major industry players
Some of the major mechanical ventilators market players are Air Liquide, Drägerwerk AG & Co. KGaA, Fisher & Paykel Healthcare Limited, Hamilton Medical, Medtronic, Koninklijke Philips N.V., Smiths Group plc, Getinge AB, VYAIRE MEDICAL, INC., and ResMed among others. Companies are adopting strategic formulations such as forward integration, new product development, geographical expansion and research collaborations in order to garner maximum revenue share and promote company growth.
Recent industry developments:
- In April 2020, Koninklijke Philips N.V. decided to upsurge its hospital ventilator production to 4,000 units/week. Additionally, the company planned to launch its Philips Respironics E30 ventilator with an immediate production of 15,000 units/week. This strategic move strengthened companies existing range of mechanical ventilators and complemented unique product portfolio, thereby offered new opportunities to design highly effective solutions for during the COVID-19.
This mechanical ventilator market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD and volume in Units from 2016 to 2027, for the following segments:
Market, By Product, 2016 – 2027 (USD Million and Units)
- Intensive Care Ventilators
- Portable Ventilators
Market, By Interface, 2016 – 2027 (USD Million and Units)
- Invasive Ventilation
- Non-invasive Ventilation
Market, By Ventilator Type, 2016 – 2027 (USD Million and Units)
- Adult Ventilators
- Neonatal Ventilators
Market, By Application, 2016 – 2027 (USD Million and Units)
- Homecare Applications
- Sleep Apnea Therapy
- Clinical Applications
Market, By Mode, 2016 – 2027 (USD Million and Units)
- Combined Mode Ventilation
- Control Mode Ventilation
- Pressure Mode Ventilator
Market, By End-use, 2016 – 2027 (USD Million and Units)
- Ambulatory Surgical Centers
The above information is provided for the following regions and countries:
- North America
- Asia Pacific
- South Korea
- Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia